Eudysmic ratio
Eudysmic Ratio
The Eudysmic Ratio is a term used in Pharmacology and Medicinal Chemistry to describe the ratio of pharmacological activity of two Enantiomers. Enantiomers are pairs of molecules that are mirror images of each other, much like left and right hands. In the context of drug development, the Eudysmic Ratio is used to quantify the difference in pharmacological activity between these two enantiomers.
Definition[edit | edit source]
The Eudysmic Ratio is defined as the ratio of the pharmacological activity of the more active enantiomer to the less active one. This ratio is used to measure the extent to which one enantiomer is more effective than the other. A high Eudysmic Ratio indicates a significant difference in the pharmacological activity of the two enantiomers, while a low ratio suggests that the enantiomers have similar levels of activity.
Importance in Drug Development[edit | edit source]
The Eudysmic Ratio is an important consideration in Drug Development. Many drugs are chiral, meaning they have two enantiomers. These enantiomers can have different levels of activity, and in some cases, one enantiomer can be harmful while the other is beneficial. By determining the Eudysmic Ratio, researchers can gain insights into the potential effectiveness and safety of a drug.
For example, the drug Thalidomide is a notorious case where one enantiomer caused severe birth defects, while the other was an effective treatment for morning sickness. If the Eudysmic Ratio had been considered during the development of Thalidomide, the tragic outcomes might have been avoided.
Challenges in Determining the Eudysmic Ratio[edit | edit source]
Determining the Eudysmic Ratio can be challenging due to the difficulty in separating enantiomers and accurately measuring their individual pharmacological activities. Advanced techniques such as Chiral Chromatography and Spectroscopy are often used to separate and analyze enantiomers.
See Also[edit | edit source]
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
